Genomics

Dataset Information

CD133+PD-L1+ cancer cells confer resistance to adoptively transferred engineered macrophage-based therapy in melanoma


ABSTRACT: CD133+PD-L1+ cancer cells confer resistance to adoptively transferred engineered macrophage-based therapy in melanoma

PROVIDER: PRJNA1188474 | ENA |

REPOSITORIES: ENA